Literature DB >> 11377290

The importance of the innate immune system in controlling HIV infection and disease.

J A Levy1.   

Abstract

The innate immune system is the first line of defense against invading pathogens and is particularly important in warding off bacterial and viral infections presenting at the mucosal cell surface. From this primitive immune response, the more sophisticated adaptive immune system was derived. Despite nearly two decades of research directed at inducing adaptive immune responses to HIV, no successful immunological therapy or vaccine has been developed. On the basis of recent observations, it is suggested that instead emphasis should now be placed on the alternative arm of the immune system, the innate immune response. Novel approaches should be developed to elicit this rapidly responding immune activity in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377290     DOI: 10.1016/s1471-4906(01)01925-1

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  26 in total

1.  Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy.

Authors:  Barbara Schmidt; Sue H Fujimura; Jeffrey N Martin; Jay A Levy
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

Review 2.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 3.  Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development.

Authors:  E G Rhee; D H Barouch
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 4.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

5.  The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.

Authors:  Gang Zhang; Dongwei Guo; Prasanta K Dash; Mariluz Araínga; Jayme L Wiederin; Nicole A Haverland; Jaclyn Knibbe-Hollinger; Andrea Martinez-Skinner; Pawel Ciborowski; Val S Goodfellow; Tadeusz A Wysocki; Beata J Wysocki; Larisa Y Poluektova; Xin-Ming Liu; JoEllyn M McMillan; Santhi Gorantla; Harris A Gelbard; Howard E Gendelman
Journal:  Nanomedicine       Date:  2015-10-22       Impact factor: 5.307

6.  Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.

Authors:  Michelle Wilkison; Katherine Gauss; Yanchao Ran; Steve Searles; David Taylor; Nicole Meissner
Journal:  Am J Pathol       Date:  2012-05-22       Impact factor: 4.307

Review 7.  Virus-host interactions in HIV pathogenesis: directions for therapy.

Authors:  J A Levy
Journal:  Adv Dent Res       Date:  2011-04

8.  Alterations of natural killer cell and T-lymphocyte counts in adults infected with human immunodeficiency virus through blood and plasma sold in the past in China and in whom infection has progressed slowly over a long period.

Authors:  Yongjun Jiang; Hong Shang; Zining Zhang; Yingying Diao; Di Dai; Wenqing Geng; Min Zhang; Xiaoxu Han; Yanan Wang; Jing Liu
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

9.  Increased Fas-mediated apoptosis in polymorphonuclear cells from HIV-infected patients.

Authors:  S Salmen; G Terán; L Borges; L Goncalves; B Albarrán; H Urdaneta; H Montes; L Berrueta
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Host sequence motifs shared by HIV predict response to antiretroviral therapy.

Authors:  William Dampier; Perry Evans; Lyle Ungar; Aydin Tozeren
Journal:  BMC Med Genomics       Date:  2009-07-23       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.